ASX 300

Right now, many high quality stocks on the ASX are trading on less than quality prices...

In this episode, Plato's Don Hamson and IML's Michael O'Neill analyse five stocks with impressive forward yields over the year ahead.

The conglomerate delivered a predictably positive set of results, with its exposure to the softer battery metals market a rare weakness.

Telstra trimmed its full-year earnings due to a weak performance from its enterprise business. But there's still plenty to be positive about

Commonwealth Bank is widely considered Australia’s highest-quality banking operation, but it’s also considered the most overvalued.

Whitehaven's earnings are down massively. But its recent acquisition of two BHP coal mines should add some muscle over the medium term.

This stock trade at a premium, but after today's result, Wilsons Advisory's Rob Crookston thinks its a buy.

Today's share price action certainly would suggest so.

Lithium will recover, iron ore remains resilient, and we’re headed for a nuclear renaissance, says Janus Henderson

It was another busy day in markets with earnings season delivering many more surprises, some good and some bad.

After today's result, Marcus Today's Henry Jennings isn't so sure...

In this wire, I analyse the opportunity in newly-listed company Light & Wonder.

It's not the end of the world if your closely watched stock starts running without you.

Earnings season is well and truly in full swing and already we're seeing the customary big swings in stock prices.

CSL has delivered bumper returns once again in its half-year report but suffered a major setback this week.

Macquarie has released its latest operational update, warning investors that economic conditions continue to weigh on its bottom line.

There may be valuation concerns around The Magnificent Seven, but there’s no reason value investors can’t still get exposure to the AI-boom.

A research report on lithium demand-supply dynamics in China suggests modest improvement, but also it's still too early to call a bottom.

Just because CSL hadn’t factored in financial benefit from CSL112, it doesn’t mean the market hadn’t.

CSL's may have dipped the ASX 200 into the red, but there were several strong performances in technology and consumer discretionary stocks.

Peter Drucker’s axiom “Culture eats strategy for breakfast” continues to apply, across industries. For investors, if culture is the sophisticated word for execution,...

A wrap-up of Australia’s two largest private health insurers ahead of their 1H2024 results, and Goldman Sachs' preferred pick

Get up to date on overnight market activity and the big events for the day.

Plus, Rudi Filapek-Vandyck shares the stocks he's watching this reporting season and over the year ahead.